000 | 01773 a2200541 4500 | ||
---|---|---|---|
005 | 20250515050719.0 | ||
264 | 0 | _c20070105 | |
008 | 200701s 0 0 eng d | ||
022 | _a0722-5091 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJohnson, V E | |
245 | 0 | 0 |
_aNo evidence for the presence of apolipoprotein epsilon4, interleukin-lalpha allele 2 and interleukin-1beta allele 2 cause an increase in programmed cell death following traumatic brain injury in humans. _h[electronic resource] |
260 |
_bClinical neuropathology _c |
||
300 |
_a255-64 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aApolipoprotein E4 _xgenetics |
650 | 0 | 4 |
_aApoptosis _xgenetics |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 |
_aBrain Injuries _xgenetics |
650 | 0 | 4 | _aCell Count |
650 | 0 | 4 | _aDNA Mutational Analysis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 |
_aGenetic Predisposition to Disease _xgenetics |
650 | 0 | 4 | _aGenetic Testing |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aHippocampus _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 |
_aInterleukin-1 _xgenetics |
650 | 0 | 4 |
_aInterleukin-1alpha _xgenetics |
650 | 0 | 4 |
_aInterleukin-1beta _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNerve Degeneration _xgenetics |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
700 | 1 | _aMurray, L | |
700 | 1 | _aRaghupathi, R | |
700 | 1 | _aStewart, J | |
700 | 1 | _aNicoll, J A R | |
700 | 1 | _aMacKinnon, M A | |
700 | 1 | _aMcIntosh, T K | |
700 | 1 | _aGraham, D I | |
773 | 0 |
_tClinical neuropathology _gvol. 25 _gno. 6 _gp. 255-64 |
|
999 |
_c16710218 _d16710218 |